* active neoplasia or in maintenance therapy * pregnancy and breastfeeding * any absolute contraindication to the use of antiplatelet drugs * pathological bleeding in progress. * recent major bleeding at any location * need to use therapeutic doses of oral anticoagulants or heparins * need to use antiplatelet in combination for clinical indication * hypersensitivity to the active substance prasugrel or any of the excipients * clinical history of stroke or transient ischemic attack (tia). * severe liver failure (child-pugh class c).

* active neoplasia or in maintenance therapy * pregnancy and breastfeeding * any absolute contraindication to the use of antiplatelet drugs * pathological bleeding in progress. * recent major bleeding at any location * need to use therapeutic doses of oral anticoagulants or heparins * need to use antiplatelet in combination for clinical indication * hypersensitivity to the active substance prasugrel or any of the excipients * clinical history of stroke or transient ischemic attack (tia). * severe liver failure (child-pugh class c).

- active neoplasia or in maintenance therapy - pregnancy and breastfeeding - any absolute contraindication to the use of antiplatelet drugs - pathological bleeding in progress. - recent major bleeding at any location - need to use therapeutic doses of oral anticoagulants or heparins - need to use antiplatelet in combination for clinical indication - hypersensitivity to the active substance prasugrel or any of the excipients - clinical history of stroke or transient ischemic attack (tia). - severe liver failure (child-pugh class c).

- active neoplasia or in maintenance therapy - pregnancy and breastfeeding - any absolute contraindication to the use of antiplatelet drugs - pathological bleeding in progress. - recent major bleeding at any location - need to use therapeutic doses of oral anticoagulants or heparins - need to use antiplatelet in combination for clinical indication - hypersensitivity to the active substance prasugrel or any of the excipients - clinical history of stroke or transient ischemic attack (tia). - severe liver failure (child-pugh class c).